COSCIENS Biopharma Inc. (CSCI : TSX)
Common Stock
$8.50
CAD
+0.40 (4.94%)
Last updated: 2026-07-13
Stock Reverse Split
11 days agoThis stock executed a 50-for-150 reverse split on July 3, 2026. Historical prices have been adjusted accordingly.
CSCI
COSCIENS Biopharma Inc.
WealthAwesomePerformance
1 Day
+4.94%
1 Week
+131.61%
1 Month
+197.20%
YTD
+193.10%
Key Statistics
Market Cap
$8.60M
52W High
$14.80
52W Low
$1.10
P/E Ratio
-
50 Day MA
$23.30
200 Day MA
$25.00
Beta
1.90
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/13/2026 | $9.00 | $9.00 | $7.88 | $8.50 | $8.50 | 4,115 |
| 7/10/2026 | $8.11 | $8.19 | $8.10 | $8.10 | $8.10 | 4,700 |
| 7/9/2026 | $12.74 | $12.74 | $11.80 | $11.80 | $11.80 | 400 |
| 7/8/2026 | $14.80 | $14.80 | $12.94 | $12.94 | $12.94 | 477 |
| 7/7/2026 | $10.55 | $10.55 | $10.55 | $10.55 | $10.55 | 100 |
| 7/6/2026 | $3.06 | $3.70 | $3.06 | $3.67 | $3.67 | 555 |
| 7/3/2026 | $3.50 | $3.66 | $3.50 | $3.66 | $3.66 | 800 |
| 7/2/2026 | $3.30 | $3.68 | $3.30 | $3.49 | $10.47 | 833 |
| 6/30/2026 | $1.00 | $1.09 | $1.00 | $1.08 | $3.24 | 5,000 |
| 6/29/2026 | $1.00 | $1.00 | $1.00 | $1.00 | $3.00 | 600 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CSCI's historical volatility
30-Day Vol
574.9%
Annualized
90-Day Vol
361.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.16
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.02 | C$1.24 – C$65.57 |
| 60 trading days | C$9.57 | C$0.58 – C$158.28 |
| 90 trading days | C$10.16 | C$0.33 – C$315.55 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Financials
- Revenue (TTM)
- $8.00M
- EBITDA
- $-7.57M
- Profit Margin
- 50.68%
- ROE (TTM)
- -61.79%
- EPS (Diluted)
- -10.56
- Book Value
- 20.45
🔄 Recent Splits
50-for-150
Jul 3, 2026
1-for-4
May 3, 2024
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About CSCI
Articles Featuring CSCI.TO
Latest articles and analysis covering CSCI.TO
What's Going On With COSCIENS Biopharma Inc. Stock Tuesday?
COSCIENS Biopharma Inc. has made headlines with its substantial stock price increase this week. Despite the lack of major company news, investor interest remains high amidst ongoing changes in its share capital structure.
Why COSCIENS Biopharma Inc. stock is rising today
COSCIENS Biopharma Inc. has gained 4.94% in the latest trading session, closing at CA$8.50. This increase may indicate growing investor confidence in the company's restructuring efforts and future prospects.
Why COSCIENS Biopharma Inc. stock is plummeting today
COSCIENS Biopharma Inc. faced a severe stock price decline of over 31% today, raising alarms about its financial health and strategic direction amidst a backdrop of operational restructuring.
Why COSCIENS Biopharma Inc. stock is plummeting today
COSCIENS Biopharma Inc. shares fell sharply by 8.81% today, closing at CA$11.80. The decline raises questions about the company's future amidst a backdrop of uncertainty and lack of recent positive developments.
Why COSCIENS Biopharma Inc. stock is plummeting today
COSCIENS Biopharma Inc. experienced a sharp decline in its stock price today, closing down 8.81%. Investors are left questioning the company's financial health amid recent operational challenges.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has seen a remarkable 187.47% increase in its stock price today, closing at CA$10.55. This surge is attributed to growing investor confidence following recent financial results and corporate announcements.
Why COSCIENS Biopharma Inc. stock is plummeting today
COSCIENS Biopharma Inc. experienced a dramatic 65.04% decline in its stock price today, closing at CA$3.66. Investors are left to ponder the implications of this drop amidst ongoing restructuring efforts and financial uncertainties.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has seen its stock price soar by 7.72% in the last trading session, closing at CA$3.49. This increase is attributed to the company's ongoing restructuring efforts aimed at enhancing operational efficiency and profitability.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. saw its stock price soar by 13.58% today, closing at CA$3.68. This surge reflects a growing optimism among investors regarding the company's future prospects.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has seen a remarkable surge in its stock price, gaining 8% in just one trading day. This rise comes amidst a backdrop of ongoing organizational changes and financial restructuring efforts that could be positively influencing investor sentiment.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. shares surged by 8.33% in the last trading session, driven by significant corporate developments. The approved share capital amendment could enhance shareholder value and attract new investors.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has seen a notable increase in its stock price today, attributed to positive corporate news regarding its share capital amendment. Investors are optimistic about the potential benefits of this strategic move.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc.'s stock surged by over 6% following the announcement of a significant share capital amendment, indicating strong investor sentiment and potential for future growth.
Why COSCIENS Biopharma Inc. stock is plummeting today
COSCIENS Biopharma Inc. is experiencing a notable decline, with its stock price dropping 6.38% amid concerns over its recent share capital amendment. Investors are advised to closely monitor the situation as the company prepares for significant changes.
Why COSCIENS Biopharma Inc. stock is tanking today
COSCIENS Biopharma Inc. experienced a 1.54% drop in stock price today, closing at CA$3.19. This decline highlights ongoing investor concerns regarding the company's restructuring efforts and financial stability.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. experienced a notable stock surge today, closing at CA$3.24, a 7.28% increase. This rise is indicative of investor optimism surrounding the company's ongoing restructuring and strategic initiatives.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has experienced a notable increase of 7.28% in today's trading session, raising questions about the factors driving this positive momentum in the stock market.
Why COSCIENS Biopharma Inc. stock is plummeting today
COSCIENS Biopharma Inc. (CSCI.TO) has seen a significant drop in its stock price, closing down 5.40% at CA$2.98. This decline raises concerns about the company's stability and future prospects.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has surged by over 10% in one trading day, closing at CA$3.15. This increase reflects growing investor confidence following the company's strategic restructuring efforts and favorable financial results.
Why COSCIENS Biopharma Inc. stock is skyrocketing today
COSCIENS Biopharma Inc. has experienced a significant one-day gain of 7.81%, closing at CA$2.90. This surge reflects investor optimism amidst the company's ongoing restructuring efforts and strategic initiatives.
Showing latest 20 articles